In STEP 1, 86% of participants reached this milestone
However, this slower digestion can disrupt your guts rhythm, leading to digestive issues like diarrhea, bloating, and nausea
As these medications including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) continue to make headlines, a more nuanced approach to their administration has evolved: microdosing
Wadden TA, Brown GK, Egebjerg C, et al
Lets start with the expectation for the number of people with diabetes: Novo bases its projections on research showing that 643 million people will have diabetes by 2030, representing a growth rate of 2% per year
Both albiglutide and dulaglutide received FDA approval for the treatment of T2DM in 2014, with dulaglutide having an additional indication since 2020 to reduce the risk of major adverse cardiovascular events (MACE) in adults with T2DM and established cardiovascular disease or multiple cardiovascular risk factors [ Table 2 ]